Estrella Immunopharma, Inc.
ESLA • NASDAQ • Stock Fundamentals
Estrella Immunopharma, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Cheng Liu, with a market cap of $49.5M.
Market Cap$49.5M
CEOCheng Liu
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 15, 2026 · 13 days agoQ1 2026
View reportFinancials
Based on Q1 2026 filing
Estrella Immunopharma, Inc. FAQ
Common questions about Estrella Immunopharma, Inc.
Estrella Immunopharma, Inc. (ESLA) has a market capitalization of $49.5M and trades on NASDAQ.